Managed Access Programs for VAY736, Ianalumab
NCT07244289
·
clinicaltrials.gov ↗
AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Primary Immune Thrombocytopenia
Sjögren's Syndrome
Interventions
DRUG:
ianalumab
Sponsor
Novartis Pharmaceuticals